Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU
NCT ID: NCT05922085
Last Updated: 2025-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2023-11-09
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Videofluoroscopy (VFS) and nasofibroscopy (NF) are the gold standard examinations for diagnosing SD. However, these two examinations are not feasible in intubated patients.
In this context, ultrasound appears to be a promising alternative to identify patients at risk of SD after extubation. This examination can be performed at the intubated patient's bedside and can be used evaluate the mobility of the structures involved in swallowing. Many studies have already shown the interest of ultrasound in the evaluation of SD but none has focused on intubated patients under respiratory assistance.
The objective of the present study is to evaluate the value of ultrasound in identifying patients at risk of presenting SD after extubation.
This monocentric study will take place in the Intensive Care Unit (ICU) of the Dijon University Hospital. The duration of participation in this research will be equal to the length of stay in the ICU. During their stay, patients will undergo ultrasound and nasofibroscopy. Information on the characteristics of the ICU stay will be collected at discharge.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Laryngeal Ultrasonography Performance in Predicting Major Post Extubation Laryngeal Edema in Intensive Care Patients
NCT01857674
Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome
NCT05492344
Prevalence, Impact and Reversibility of Acute Diaprhagmatic Dysfunction in Acute Respiratory Detresse
NCT04106128
The Role of Lung and Diaphragm Ultrasonography in Predicting Clinical Progression in Hypoxemic Respiratory Failure
NCT06706830
Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory Distress
NCT04520815
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient under mechanical ventilation for at least 48 hours
Ultrasound
performed within 3 hours prior to extubation
nasofibroscopie
performed within 24 to 36 hours after extubation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
performed within 3 hours prior to extubation
nasofibroscopie
performed within 24 to 36 hours after extubation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Major
* On mechanical ventilation for at least 48 hours
* Affiliated to national health insurance
Exclusion Criteria
* Under legal protection (curatorship, guardianship, safeguard of justice)
* Pregnant, parturient or breastfeeding woman
* Refusal to participate by the patient or their proxy (or an immediate family member)
* Cognitive disorders incompatible with the understanding of instructions
* Previously diagnosed swallowing disorders
* With a neurological condition at the origin of the SD (stroke, ALS...)
* Treated for a lesion of the aerodigestive tract (by surgery, radiotherapy or radio-chemotherapy)
* presence of wounds or dressings on the areas to be evaluated that prevent ultrasound measurements
* Patient for whom a decision to limit or stop life support treatments has been taken collegially within the intensive care unit
* With one or more contraindications to performing NF:
* Anatomical features not compatible with NF: mainly deviation of the nasal septum.
* Risk of significant otorhinolaryngological bleeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PINEDA APPARA 2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.